[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks for 2025 and Beyond",
    "summary": "We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]",
    "url": "https://finnhub.io/api/news?id=c6c4d20829490deadcce3c4efcfabc9c6eaee803c16aa09e7eebfa8b030a3f9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746863914,
      "headline": "Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks for 2025 and Beyond",
      "id": 134379504,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]",
      "url": "https://finnhub.io/api/news?id=c6c4d20829490deadcce3c4efcfabc9c6eaee803c16aa09e7eebfa8b030a3f9b"
    }
  },
  {
    "ts": null,
    "headline": "Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit",
    "summary": "Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday.  A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million.  “Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,” the statement added.",
    "url": "https://finnhub.io/api/news?id=f49d7400ff10b1d4624fe3aab551880540f1b09489a7bd6a9ec7d3a940b44286",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746843822,
      "headline": "Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit",
      "id": 134362440,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday.  A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million.  “Plavix has helped millions of people with cardiovascular disease around the world for nearly 30 years and it continues to be endorsed as a first-line therapy by leading treatment guidelines across the globe,” the statement added.",
      "url": "https://finnhub.io/api/news?id=f49d7400ff10b1d4624fe3aab551880540f1b09489a7bd6a9ec7d3a940b44286"
    }
  }
]